Sowell Financial Services’s Checkpoint Therapeutics CKPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-349
Closed -$8K 910
2021
Q1
$8K Sell
349
-353
-50% -$11.8K ﹤0.01% 2394
2020
Q4
$19K Buy
+702
New +$17.8K ﹤0.01% 1763

Other funds holding CKPT

Sowell Financial Services's CKPT Position: Q2 2021 in Review

Sowell Financial Services sold out of Checkpoint Therapeutics (CKPT) in Q2 2021, closing a stake of 349 shares — an estimated $8K sold.

Sowell Financial Services first reported a position in CKPT in Q4 2020 and held it in 2 quarters. The position peaked at $19K in Q4 2020. 69 funds tracked by Wall St. Rank hold CKPT as of Q2 2021.

  • Sowell Financial Services reported no remaining Checkpoint Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 349 Checkpoint Therapeutics shares in Q2 2021, an estimated $8K.
  • Sowell Financial Services first reported a position in Checkpoint Therapeutics in Q4 2020 and held it in 2 quarters.
  • Sowell Financial Services's Checkpoint Therapeutics position peaked at $19K in Q4 2020.
  • 69 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.